Instrument Inactif

Communiqués Arch Therapeutics, Inc. Other OTC

Actions

ARTH

US03939W1099

Equipement, fournitures et distribution médicale

Communiqués

08/11/24	Arch Therapeutics : Material Agreement Form 8 K	PU
01/10/24	Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	AQ
06/05/24	Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)	AQ
03/04/24	Arch Therapeutics : New Financial Obligation - Form 8-K	PU
15/12/23	Arch Therapeutics : New Financial Obligation - Form 8-K	PU
09/11/23	Arch Therapeutics Provides Year End Operational Update	AQ
02/11/23	Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	AQ
13/09/23	Arch Therapeutics Provides AC5® Commercialization Update	AQ
08/09/23	Arch Therapeutics Completes Financing as Bridge to Uplisting	AQ
25/04/23	Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)	AQ
05/04/23	Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect	AQ
17/03/23	Arch Therapeutics : Material Agreement - Form 8-K	PU
09/03/23	Arch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services	AQ
07/03/23	Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities	AQ
16/02/23	ARCH THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
18/01/23	Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System	AQ
17/01/23	ARCH THER : Modification to Rights of Security Holders - Form 8-K	PU
17/01/23	Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National Exchange	AQ
28/12/22	ARCH THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
05/12/22	The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics’ AC5® Advanced Wound System	AQ
02/12/22	ARCH THERAPEUTICS, INC. : Other Events (form 8-K)	AQ
18/10/22	Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall	AQ
11/10/22	Arch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) Fall	AQ
10/10/22	Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care	PU
30/09/22	ARCH THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ